Genetic link found in migraines

By Admin
For the first time three gene variations have been found which scientists believe are a link to headaches, in particular migraines. Migraines are appro...

For the first time three gene variations have been found which scientists believe are a link to headaches, in particular migraines.

Migraines are approximately three or four times more likely to affect women and one of genes that were identified were found exclusively in females.

It is now hoped that the new information will eventually lead to a better understanding of migraines and could possibly pave the way for revolutionary treatments.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Twenty percent of the world’s population suffer from migraines and although the cause of the condition is largely unknown there have been suspicions that genetic inheritance plays a significant part.

The groundbreaking research was led by the Brigham and Women’s Hospital in Boston, U.S and the team of researchers found three variations of the genes PRDM16, TRPM8 and LRP1.

These variations were more common in migraine sufferers and the scientists believe they increase the risk of a migraine by 10-15 percent.

The TRPM8 gene was only linked to migraines in women. Both the PRDM16 gene and the TRPM8 gene were linked specifically to migraines rather than other types of headaches.

Meanwhile, the LRP1 gene is responsible for sensing the external world and the researchers believe it could be involved in the promotion of migraine attacks.

 The genes of over 23,000 women were look at as part of the study and over 5,000 of these women were migraine sufferers. 

Share

Featured Articles

Elsevier: Emerging Tech & Enhanced Patient-Centred Care

Dr Ximena Alvira, Clinical Executive at Elsevier, shares how AI technology can build stronger patient-centred care across the healthcare sector

Personalised Omnichannel Healthcare Professional Experience

Kamya Elawadhi, Chief Client Officer at Doceree, discusses targeted media strategies for personalised omnichannel healthcare professional experience

McKinsey's APIs Healthcare Scope 3 advice to Big Pharma

McKinsey advises active pharmaceutical ingredients makers on decarbonisation to help pharma companies cut Scope 3 emissions.

Latest Apple Devices to Address Sleep Apnea & Hearing Health

Technology & AI

Grifols & Orange Business Launch Egypt Plasma Project

Medical Devices & Pharma

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Medical Devices & Pharma